Oxford Nanopore provides updated kits and protocols for rapid, scalable and low-cost sequencing of SARS-CoV-2 genomes

Wed 5th May 2021 Oxford Nanopore has released new protocols enabling the rapid, cost effective sequencing of SARS-CoV-2 — the virus that causes COVID-19. Research teams are able to access sequencing technology in days, without capital cost, for quick set-up of rapid turnaround SARS-CoV-2 sequencing.  From initial characterisation of the SARS-CoV-2 virus genome to the rapid identification of variants, researchers have been... Read more

Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories

Labs processing ~2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs BREA, CALIF., MAY. 4, 2021 — Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that... Read more

New Cypher VRS1250 Video-Rate Atomic Force Microscope Enables True Video-Rate Imaging at up to 45 Frames per Second

29 Apr April 27, 2021 (Santa Barbara, CA) Oxford Instruments Asylum Research today announced the launch of the new Cypher VRS1250 video-rate atomic force microscope (AFM). Twice as fast as the first-generation Cypher VRS, the new AFM enables scan rates up to 1250 lines/second and frame rates up to 45 frames/second. This new higher speed... Read more

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people

Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths globally² Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment Early diagnosis and treatment can contribute to saving or improving people’s lives and could help healthcare systems... Read more

Bio-Techne Announces Commercial Release of Novel DNAscope In Situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

APRIL 27, 2021 Pushing the Spatial Genomics Frontier One Biomolecule at a Time from RNA to DNA MINNEAPOLIS, April 27, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization (ISH)... Read more

Danaher Announces Renowned Scientists To Join New Scientific Advisory Board

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy. The Board will help the company protect and grow existing... Read more

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of... Read more

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina’s comprehensive genomic profiling assay, TruSight™ Oncology 500 (TSO 500). This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with... Read more